Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
Katz
L Jay
LJ
Wills Eye Hospital, Philadelphia, PA 19107, USA. ljk22222@aol.com
Cohen
John S
JS
Batoosingh
Amy L
AL
Felix
Carlos
C
Shu
Vincent
V
Schiffman
Rhett M
RM